We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Patricia
Schartau
patricia.schartau@ucl.ac.uk
Patricia
Schartau
patricia.schartau@ucl.ac.uk
Patricia
Schartau
patricia.schartau@ucl.ac.uk
Malignant neoplasms of male genital organs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
In the UK, prostate cancer is the most common cancer (one in eight) with the rate being higher amongst Black African or Caribbean men (one in four). Black men develop prostate cancer at younger ages, are diagnosed later and their cancer is likely to progress faster. In the UK, Black men are 2.5 times more likely to die of prostate cancer compared to White men. Genetic factors alone cannot account for this. Whilst a range of barriers and causes have been identified, we don’t understand their relative importance or how they interact to create inequalities across prostate cancer care. We know even less about how they can be addressed.
We aim to explore what enables Black men to seek prostate cancer screening or engage with prostate cancer healthcare, and what barriers there are, from the perspectives of:
(i) Black men eligible for screening
(ii) Black male prostate cancer patients
(iii) Healthcare professionals
This project will be a qualitative study comprising of three elements;
(1) Semi-structured focus groups (discussion groups) or interviews if strongly preferred with approximately 24 Black prostate cancer patients and Black men eligible for screening to discuss what helps them (facilitators) to seek prostate cancer screening and engage with primary healthcare services post-diagnosis, and what stops them (barriers).
(2) Interviews with around 20 healthcare professionals who are involved with looking after these patients.
(3) An online workshop to exchange learning from our research, expand our research network and agree on a primary care intervention from our findings (no ethics required)
This research will help us understand the barriers and facilitators faced by Black men to engage with prostate cancer care from screening to survivorship. This knowledge can be applied to other diseases where Black men/women carry a disproportionate burden and allows us to plan the development of a primary care intervention to reduce inequalities.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
1) Current inpatient in hospital 2) Deemed unsuitable by HCPs e.g. palliative or end-of-life care; recently bereaved 3) People lacking capacity to consent
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Patricia
Schartau
patricia.schartau@ucl.ac.uk
Patricia
Schartau
patricia.schartau@ucl.ac.uk
Patricia
Schartau
patricia.schartau@ucl.ac.uk
The study is sponsored by University College London and funded by NIHR School for Primary Care Research .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 56335
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
